Exane Derivatives’s Hercules Capital HTGC Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGC
SIS
BTCPP
ACM
Exane Derivatives's HTGC Position: Q2 2022 in Review
Exane Derivatives held its Hercules Capital (HTGC) position steady in Q2 2022 at 3,094 shares worth $41.7K. The position accounts for 0.02% of the portfolio, ranked #325.
Exane Derivatives first reported a position in HTGC in Q1 2021 and has held it in 6 quarters since. The position peaked at $82.8K in Q2 2021. 249 funds tracked by Wall St. Rank hold HTGC as of Q2 2022.
- Exane Derivatives held 3,094 shares of Hercules Capital worth $41.7K as of Q2 2022.
- Exane Derivatives left its Hercules Capital share count unchanged in Q2 2022.
- Hercules Capital made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #325 holding.
- Exane Derivatives first reported a position in Hercules Capital in Q1 2021 and has held it in 6 quarters since.
- Exane Derivatives's Hercules Capital position peaked at $82.8K in Q2 2021.
- 249 funds tracked by Wall St. Rank held Hercules Capital as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.